PharmaBoardroom

Newly Independent Sandoz Predicts $3 Billion in Biosimilars Sales…

As former parent company Novartis centres its efforts on its “pure-play” innovative medicines business, Sandoz is increasingly betting on…

Hong Kong: Local Market Insights from MNC Heads

While much of PharmaBoardroom's recent report on Hong Kong and the Greater Bay Area looks at how Hong Kong is attempting to position itself as a…

5 Insights on UAE Product Launch Strategies

Thanks to favourable regulations from the Ministry of Health and Prevention (MoHaP) which include fast-track regulatory pathways, patients in the UAE…

The Long Read: Belgium – One of a Kind

Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish…

Pfizer’s Albert Bourla is Pharma’s Top Social Media Performer

Pfizer CEO Albert Bourla is the pharma executive with the biggest impact on social media, according to a new study. While busy industry leaders may…

Derek Chang – Head, Novartis Hong Kong

Novartis, one of the world's largest biopharma companies, has secured approval and market access for two of its most advanced cell and gene treatments…

Mohamed Ezz Eldin – Head, Novartis Gulf

Mohamed Ezz Eldin oversees Novartis operations in the UAE, Kuwait, Bahrain, Oman and Qatar. He outlines how the company's strategy has evolved in the…

Four Key Trends in Belgian Clinical Trials

Thanks to its world-renowned networks of medical and academic institutions, the long-standing presence of Big Pharma, and a favourable regulatory…

Top 20 Global Pharma Companies 2023

The top 20 pharmaceutical companies in the world for the past year, according to Pharmaceutical Executive's latest annual rankings. Pfizer holds sway…

Belgium: 5 Pharma Industry Leaders Speak Out on Access Issues

Despite the thriving life sciences ecosystem that has made Belgium one of the top European destinations for clinical trials, the country continues to…

Federico Mambretti – Country President, Novartis Belgium…

Novartis is one of Belgian pharma's biggest investors across manufacturing and R&D, contributing EUR 598.9 million to GDP in 2022, creating 4,403…

Top 10 Pharma Companies in Thailand

The top ten companies in the USD 6.9 billion Thai pharma market for 2021 ranked by market share, compiled by Thai banking firm Krungsti. Three of the…

Tagged with Novartis